Don’t Leave Your Exit to Chance: Why IP Strategy is the Foundation of the “End Game”

What separates a successful life science exit from a missed opportunity? Often, it isn’t just the quality of the science, but the timing and precision of the IP strategy.

At the recent “The End Game” event, hosted by Ventures Accelerated in Stockholm, AWA’s Niklas Mattsson and a panel of international investors, including Josefine Persson (HealthCap), Gabor Illes (Hopkins Capital) and moderator Bita Sehat (Trill Impact Ventures), discussed a critical truth: the commercial focus must be present from the start.

Start with the End in Mind
Many founders make the mistake of viewing IP as a legal formality to be handled after the science is proven. However, the most successful exits are those where the IP was built with the intended outcome in mind.

Your IP strategy should differ fundamentally depending on your goal:

• Product Company: Requires deep, defensible protection for individual assets.
• Platform Provider: Requires broad IP that enables licensing and royalty streams.
• Speed-to-Market Specialist: May rely more on know-how and trade secrets to maintain a competitive edge.

If you don’t know your “end game,” you cannot possibly know what to claim in your patent applications.

The “Investment vs Cost” Trap
One of the most striking takeaways from the panel was the mindset gap between US and European startups. While US companies typically view IP as a primary investment—spending aggressively early on to secure a dominant position—European firms often treat it as a cost centre to be minimised.

In the Nordics, there is a strong tradition of scientific excellence, but science alone does not create value; the protection of that science does. To avoid sub-optimisation, founders must shift their perspective: IP is not a bill to be paid, but an asset to be built.

Adapting to a New Era of AI
As we look toward the future, AI is rewriting the rules of the game. The ability to leverage AI tools to iterate faster and think more strategically will be the new competitive advantage. At AWA, we believe the role of the IP attorney is evolving—from a filing agent to a strategic partner who uses every available tool to accelerate a client’s journey toward a successful exit.

The Bottom Line
Whether your goal is a strategic acquisition, a partnership, or independent growth, the “End Game” begins on day one. Deal with your IP early, treat it as an investment, and build your portfolio with your final destination in mind.